Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation...
76 insider purchases on record · latest filing 2026-08-18.
Insiders have also filed 218 sale transactions at VRCA.